Epi Vax Oncology, Inc. announced it raised $375,000 in an initial filing from an offering of $1.25 Million
Epi Vax Oncology, Inc. announced it raised $375,000 in an initial filing from an offering of $1.25 Million
10/07/19, 7:51 PM
Location
new yorkMoney raised
$375,000
Industry
biotechnology
Round Type
seed
Company Info
Location
180 varick street
new york, new york, united states
Additional Info
EpiVax Oncology, a precision cancer immunotherapy company, is developing mutanome-directed, neo-epitope personalized therapeutic vaccines. EpiVax Oncology’s therapeutic vaccines are customized and specifically designed for each patient’s tumors, leveraging advances in next generation immunology.